These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 32236634)
1. HS‑146, a novel phosphoinositide 3‑kinase α inhibitor, induces the apoptosis and inhibits the metastatic ability of human breast cancer cells. Kim OH; Lee JH; Mah S; Park SY; Hong S; Hong SS Int J Oncol; 2020 Jun; 56(6):1509-1520. PubMed ID: 32236634 [TBL] [Abstract][Full Text] [Related]
2. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943 [TBL] [Abstract][Full Text] [Related]
3. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways. Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731 [TBL] [Abstract][Full Text] [Related]
4. PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells. Yang K; Tang XJ; Xu FF; Liu JH; Tan YQ; Gao L; Sun Q; Ding X; Liu BH; Chen QX Oncol Rep; 2020 Mar; 43(3):773-782. PubMed ID: 32020210 [TBL] [Abstract][Full Text] [Related]
5. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1. Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169 [TBL] [Abstract][Full Text] [Related]
6. Arsenic disulfide‑induced apoptosis and its potential mechanism in two‑ and three‑dimensionally cultured human breast cancer MCF‑7 cells. Zhao Y; Onda K; Yuan B; Tanaka S; Kiyomi A; Sugiyama K; Sugiura M; Takagi N; Hirano T Int J Oncol; 2018 Jun; 52(6):1959-1971. PubMed ID: 29620191 [TBL] [Abstract][Full Text] [Related]
7. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling. Zhao X; Guo X; Shen J; Hua D Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572 [TBL] [Abstract][Full Text] [Related]
8. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1. Bhowmik T; Gomes A Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778 [TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of the HDAC inhibitor, 3β,6β‑dihydroxyurs‑12‑en‑27‑oic acid, in MCF‑7 breast cancer cells via the inhibition of Akt/mTOR pathways. Lim JS; Kyung SY; Jeon Y; Kim IS; Kwak JH; Kim HS Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36633143 [No Abstract] [Full Text] [Related]
11. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines. Wang L; Wu J; Lu J; Ma R; Sun D; Tang J Mol Med Rep; 2015 Feb; 11(2):931-9. PubMed ID: 25355053 [TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells. Aggarwal S; John S; Sapra L; Sharma SC; Das SN Cancer Chemother Pharmacol; 2019 Mar; 83(3):451-461. PubMed ID: 30519710 [TBL] [Abstract][Full Text] [Related]
13. A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway. Li GY; Jung KH; Lee H; Son MK; Seo J; Hong SW; Jeong Y; Hong S; Hong SS Cancer Lett; 2013 Feb; 329(1):59-67. PubMed ID: 23085493 [TBL] [Abstract][Full Text] [Related]
14. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Zhao Z; Li C; Xi H; Gao Y; Xu D Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis and suppression of angiogenesis of hepatocellular carcinoma by HS-159, a novel phosphatidylinositol 3-kinase inhibitor. Yun SM; Lee JH; Jung KH; Lee H; Lee S; Hong S; Hong SS Int J Oncol; 2013 Jul; 43(1):201-9. PubMed ID: 23604199 [TBL] [Abstract][Full Text] [Related]
16. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells. Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818 [TBL] [Abstract][Full Text] [Related]
17. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells. Zhao Y; Onda K; Sugiyama K; Yuan B; Tanaka S; Takagi N; Hirano T Oncol Rep; 2019 Jan; 41(1):27-42. PubMed ID: 30320388 [TBL] [Abstract][Full Text] [Related]
19. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling. Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875 [TBL] [Abstract][Full Text] [Related]
20. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway. Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]